| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cisplatin | GDSC1000 | pan-cancer | AAC | 0.065 | 0.07 |
| mRNA | avicin D | CTRPv2 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | -0.072 | 0.07 |
| mRNA | AZ628 | GDSC1000 | pan-cancer | AAC | 0.089 | 0.07 |
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | -0.075 | 0.07 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.07 |
| mRNA | selumetinib:BRD-A02303741 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.068 | 0.07 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.15 | 0.07 |
| mRNA | JW-7-52-1 | GDSC1000 | pan-cancer | AAC | 0.093 | 0.08 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.093 | 0.08 |